Back to mobile site

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Reports FY24 results

March 31, 2025 4:12 PM EDT

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported FY24 EPS of ($0.90).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK